GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Zhenyuan Share Co Ltd (SZSE:000705) » Definitions » EBIT

Zhejiang Zhenyuan Share Co (SZSE:000705) EBIT : ¥114 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Zhejiang Zhenyuan Share Co EBIT?

Zhejiang Zhenyuan Share Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ¥27 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥114 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Zhejiang Zhenyuan Share Co's annualized ROC % for the quarter that ended in Mar. 2024 was 4.06%. Zhejiang Zhenyuan Share Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Zhejiang Zhenyuan Share Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.41%.


Zhejiang Zhenyuan Share Co EBIT Historical Data

The historical data trend for Zhejiang Zhenyuan Share Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Zhenyuan Share Co EBIT Chart

Zhejiang Zhenyuan Share Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 257.49 115.83 107.04 106.13 113.40

Zhejiang Zhenyuan Share Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.85 41.53 27.04 17.98 26.99

Competitive Comparison of Zhejiang Zhenyuan Share Co's EBIT

For the Drug Manufacturers - General subindustry, Zhejiang Zhenyuan Share Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Zhenyuan Share Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Zhenyuan Share Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Zhejiang Zhenyuan Share Co's EV-to-EBIT falls into.



Zhejiang Zhenyuan Share Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥114 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Zhenyuan Share Co  (SZSE:000705) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Zhejiang Zhenyuan Share Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=94.7 * ( 1 - 23.72% )/( (1768.42 + 1790.676)/ 2 )
=72.23716/1779.548
=4.06 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2939.079 - 711.77 - ( 458.889 - max(0, 779.33 - 1871.42+458.889))
=1768.42

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3075.252 - 783.75 - ( 500.826 - max(0, 922.426 - 1998.629+500.826))
=1790.676

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Zhejiang Zhenyuan Share Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=107.94/( ( (663.859 + max(623.23, 0)) + (690.682 + max(608.761, 0)) )/ 2 )
=107.94/( ( 1287.089 + 1299.443 )/ 2 )
=107.94/1293.266
=8.35 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(616.629 + 679.416 + 75.512) - (711.77 + 0 + 36.557)
=623.23

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(681.851 + 645.754 + 92.979) - (783.75 + 0 + 28.073)
=608.761

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Zhejiang Zhenyuan Share Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=113.536/2099.312
=5.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Zhenyuan Share Co EBIT Related Terms

Thank you for viewing the detailed overview of Zhejiang Zhenyuan Share Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Zhenyuan Share Co (SZSE:000705) Business Description

Traded in Other Exchanges
N/A
Address
No. 289 Jiefang North Road, Zhejiang Province, Shaoxing, CHN, 312000
Zhejiang Zhenyuan Share Co Ltd is a China based pharmaceutical company. It is engaged in the engaged in the production and operation of proprietary Chinese medicines, Chinese herbal medicines, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, narcotic drugs, psychotropic drugs, medical devices, chemical reagent and others. Further, the firm's business scope covers the pharmaceutical industry, pharmaceutical business, pharmaceutical logistics and health service industry. It holds presence in both Chinese and international market.
Executives
Zhang Yan Na Supervisors
Wu Hai Ming Director
Chen Fu Gen Directors, executives
Wei Min Executives
He Yi Qiang Directors, executives
Dong Jin Biao Supervisors
Xuan Le Xin Supervisors
Jiang Guan Gen Supervisors
Song Yi Ting Directors, executives
Li Cheng Hua Executives
He Yu Long Directors, executives
Li Yang Executives
Ruan Jian Chang Director
Jin Ming Hua Executives
Zhou Qian Li Secretary Dong

Zhejiang Zhenyuan Share Co (SZSE:000705) Headlines

No Headlines